Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Johnson and Johnson
AstraZeneca
Dow
McKinsey

Last Updated: June 27, 2022

Agios Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AGIOS PHARMS INC, and what generic alternatives to AGIOS PHARMS INC drugs are available?

AGIOS PHARMS INC has one approved drug.

There are seven US patents protecting AGIOS PHARMS INC drugs.

There are one hundred and sixteen patent family members on AGIOS PHARMS INC drugs in forty countries.

Summary for Agios Pharms Inc
International Patents:116
US Patents:7
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Agios Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agios Pharms Inc PYRUKYND mitapivat sulfate TABLET;ORAL 216196-001 Feb 17, 2022 RX Yes No 9,682,080 See Plans and Pricing See Plans and Pricing
Agios Pharms Inc PYRUKYND mitapivat sulfate TABLET;ORAL 216196-003 Feb 17, 2022 RX Yes Yes See Plans and Pricing See Plans and Pricing
Agios Pharms Inc PYRUKYND mitapivat sulfate TABLET;ORAL 216196-002 Feb 17, 2022 RX Yes No 10,632,114 See Plans and Pricing See Plans and Pricing
Agios Pharms Inc PYRUKYND mitapivat sulfate TABLET;ORAL 216196-001 Feb 17, 2022 RX Yes No 11,234,976 See Plans and Pricing See Plans and Pricing
Agios Pharms Inc PYRUKYND mitapivat sulfate TABLET;ORAL 216196-001 Feb 17, 2022 RX Yes No See Plans and Pricing See Plans and Pricing
Agios Pharms Inc PYRUKYND mitapivat sulfate TABLET;ORAL 216196-002 Feb 17, 2022 RX Yes No 9,980,961 See Plans and Pricing See Plans and Pricing
Agios Pharms Inc PYRUKYND mitapivat sulfate TABLET;ORAL 216196-003 Feb 17, 2022 RX Yes Yes 8,785,450 See Plans and Pricing Y Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Agios Pharms Inc Drugs

Country Patent Number Estimated Expiration
Costa Rica 20120001 See Plans and Pricing
Argentina 077292 See Plans and Pricing
Slovenia 2448582 See Plans and Pricing
South Korea 102024027 See Plans and Pricing
Japan 2021504338 See Plans and Pricing
Mexico 2019009856 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2016201227 See Plans and Pricing
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Johnson and Johnson
Medtronic
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.